16-fluoroestradiol has been researched along with Epithelial Ovarian Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arts, HJ; Bongaerts, AH; de Vries, EF; de Vries, EG; Glaudemans, AW; Hollema, H; Hospers, GA; Jager, NM; Reyners, AK; van Kruchten, M | 1 |
1 other study(ies) available for 16-fluoroestradiol and Epithelial Ovarian Cancer
Article | Year |
---|---|
Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Estradiol; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Receptors, Estrogen; Sex Hormone-Binding Globulin; Tomography, X-Ray Computed | 2015 |